Unichem Laboratories

May 22 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• MARCH-QUARTER CONSOL PROFIT 109.1 MILLION RUPEES

• MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 5.75 BILLION RUPEES

• PABITRAKUMAR BHATTACHARYYA RE-APPOINTED AS MD AND CEO

Source text: [ID:]

Further company coverage: UNLB.NS

(([email protected];))

Feb 5 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES LTD DEC-QUARTER CONSOL PAT 2.64 BILLION RUPEES

• UNICHEM LABORATORIES LTD DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 5.21 BILLION RUPEES

Source text: [ID:]

Further company coverage: UNLB.NS

(([email protected];))

Feb 2 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• USFDA INSPECTION AT UNICHEM'S KOLHAPUR FACILITY COMPLETED

Source text: ID:nNSE60rl66

Further company coverage: UNLB.NS

(([email protected];))

Sept 18 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES - GETS DEMAND NOTICE FROM EUROPEAN COMMISSION FOR FINE OF 19.5 MILLION EURO

Source text: ID:nnAZN4JIZ3Z

Further company coverage: UNLB.NS

(([email protected];))

** Shares of Biome Australia BIO.AX rise as much as 6.9% to A$0.545, its biggest pct rise since July 28; stock last up 2%

** The biotherapeutics firm executes trading terms with primary health care services provider Green Cross Health for the retail launch of Activated Probiotics across New Zealand's pharmacy network

** Activated Probiotics to commence retail launch into Life Pharmacy and UniChem pharmacies from September 2025

** Stock is up 11.9% YTD, including the session's moves

(Reporting by Anjali Singh in Bengaluru)

(([email protected];))

Aug 26 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES LTD - USFDA INSPECTED UNICHEM'S ROHA API FACILITY IN JUNE 2025

• UNICHEM LABORATORIES LTD - USFDA CLASSIFIES INSPECTION AS VOLUNTARY ACTION INITIATED

Source text: ID:nBSE1R2rcF

Further company coverage: UNLB.NS

(([email protected];))

** Nomura says IPCA Laboratories' IPCA.NS weaker-than-expected Q1 performance can be largely attributed to subsidiary Unichem Laboratories' UNLB.NS low gross margin, low domestic formulation growth, soft institutional sales

** Co holds 52.67% stake in UNLB, which was acquired in 2023

** IPCA's Q1 sales, profit, EBITDA below Nomura's estimates; but consol profit, revenue up ~21%, ~10% y/y, respectively

** API segment revenue up 13% y/y, led by 28% y/y growth in exports; domestic API sales down 18% y/y

** IPCA up 1.4% on the day, trims YTD losses to ~20%

(Reporting by Vijay Malkar)

(([email protected];))

** Shares of Unichem Laboratories UNLB.NS rise 3% to 626 rupees, hitting highest level since April 2025

** Pharmaceutical co posts Q4 consolidated profit of 529.7 million rupees ($6.15 million) vs year-ago loss of 1.36 bln rupees; revwnuw up 28% Y/Y

** Co reports last year's Q4 earnings were hit by "major" fine by European Commission

** Profits improved with no such cost this year, Unichem says

** Over 566,776 shares traded, ~8.4x the 30-day moving average

** Stock down 14.5% YTD

($1 = 86.0500 Indian rupees)

(Reporting by Rudra Pratap Singh in Bengaluru)

(([email protected]))

March 28 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES LTD - TO TRANSFER 100% STAKE IN UNICHEM IRELAND TO IPCA LABORATORIES

Source text: ID:nNSEc7C7qB

Further company coverage: UNLB.NS

(([email protected];;))

March 20 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• COMPLETES PHASE I CAPACITY EXPANSION OF API PLANT

Source text: ID:nBSE9rGmJY

Further company coverage: UNLB.NS

(([email protected];;))

** Shares of Unichem Laboratories UNLB.NS rise 5.6% to 639 rupees

** Pharmaceutical co to sell 3.4 acres of land and old construction building area at Prabhat Estate in Mumbai for 2.79 bln rupees ($31.9 mln) to Macrotech Developers MACE.NS

** Stock set to snap five-session losing streak

** UNLB down ~14.2% in 2025 vs 83.2% gains in 2024

($1 = 87.3480 Indian rupees)

(Reporting by Vijay Malkar)

(([email protected];))

Feb 6 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABS DEC-QUARTER CONSOL PAT 578.5 MILLION RUPEES

• UNICHEM LABS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 5.33 BILLION RUPEES

Source text: ID:nnAPN2N3ISB

Further company coverage: UNLB.NS

(([email protected];))

Jan 24 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• GETS GST ORDER WITH INTEREST OF 65.9 MILLION RUPEES, PENALTY OF 870.7 MILLION RUPEES

Source text: ID:nBSE3fV1V2

Further company coverage: UNLB.NS

(([email protected];;))

** Unichem Laboratories UNLB.NS gains 2.1% to 895.30 rupees

** Pharmaceutical co's Q2 consol profit at 304.9 mln rupees ($3.6 mln) vs year-ago loss of 244.9 mln rupees; rev up 11.2% y/y

** Around 232,749 shares traded, 1.5x the 30-day avg

** Relative strength index (RSI) rises to 71.7, suggesting stock might be overbought - LSEG

** UNLB up ~121% YTD

($1 = 84.3710 Indian rupees)

(Reporting by Vijay Malkar)

(([email protected];))

** Shares of Unichem Laboratories UNLB.NS up 3.5% at 681.1 rupees

** Specialty pharmaceutical co enters agreements to purchase all rights in product approvals and goodwill associated with nine abbreviated new drug applications (ANDA) of Bayshore USA for $2.7 million

** Co's U.S. unit to buy U.S. generics formulations marketing/distribution business of Bayshore USA for $10 million

** Stock up 67% YTD

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

Sept 30 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• APPROVED ENTERING INTO AGREEMENTS WITH BAYSHORE PHARMACEUTICALS LLC

• PURCHASE OF RIGHTS, TITLE, INTEREST IN PRODUCT, GOODWILL ASSOCIATED WITH 9 ANDAS OF BAYSHORE USA

• PURCHASE FOR $2.7 MILLION

• UNIT TO BUY USA GENERICS FORMULATIONS MARKETING/DISTRIBUTION BUSINESS OF BAYSHORE USA

• UNIT'S DEAL FOR $10 MILLION

Source text for Eikon: ID:nBSENh6PT

Further company coverage: UNLB.NS

(([email protected];;))

Sept 23 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES - TO CONSIDER CONSOLIDATION OF GENERICS FORMULATIONS BUSINESS IN US MARKET

Source text for Eikon: ID:nBSE9Qs9KG

Further company coverage: UNLB.NS

(([email protected];))

** Shares of Unichem Laboratories UNLB.NS rise 2.3% to 579.6 rupees

** Co said on Tuesday that US FDA classified inspection at its Goa facility as voluntary action indicated (VAI)

** VAI indicates that no administrative or regulatory measures were taken following the inspection

** More than 53,000 shares change hands, 1.1x its 30-day avg

** Stock up 42% so far this year

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

Aug 8 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES JUNE-QUARTER CONSOL PAT 92.6 MILLION RUPEES

• UNICHEM LABORATORIES JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 4.46 BILLION RUPEES

• UNICHEM LABORATORIES LTD - NAMES SANJAY JAIN AS CFO

Source text for Eikon: [ID:]

Further company coverage: UNLB.NS

(([email protected];))

June 27 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• COURT OF JUSTICE OF EU UPHELD FINE OF EURO 13.96 MILLION ON CO, ITS UNIT NICHE GENERICS

• FINE PERTAINING TO PATENT DISPUTE SETTLEMENT AGREEMENT DONE FOR PERINDOPRIL DRUG MATTER

Further company coverage: UNLB.NS

(([email protected];))

May 31 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• UNICHEM LABORATORIES LTD - SANDIP GHUME RESIGNS AS DEPUTY CHIEF FINANCIAL OFFICER

Source text for Eikon: ID:nBSE55L30S

Further company coverage: UNLB.NS

(([email protected];))

** Shares of Unichem Laboratories UNLB.NS down 2.3% at 555 rupees

** Stock on track to snap three straight sessions of gains

** The pharma co's March-qtr consol loss after tax widens to 1.29 bln rupees ($15.5 mln) from 442.7 mln rupees a year ago

** UNLB incurred a one-time expense of 1.26 bln rupees

** Including session's losses, stock up ~37% YTD

($1 = 83.2410 Indian rupees)

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

May 22 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• MARCH-QUARTER CONSOL LOSS AFTER TAX 1.29 BILLION RUPEES VERSUS LOSS 442.7 MILLION RUPEES

• MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.32 BILLION RUPEES VERSUS 4.02 BILLION RUPEES

Further company coverage: UNLB.NS

(([email protected];))

** Shares of Unichem Laboratories UNLB.NS surge 17.3% to a record high to 548.7 rupees; last up ~13%

** Pharmaceutical firm reported Dec-qtr profit of 839.9 mln rupees ($10.1 mln) vs yr-ago loss of 639.3 mln rupees; rev from ops rose nearly 44%

** Stock on track for best day since early-April 2023 if gains hold

** More than 1 mln shares change hands by 2:30 p.m. IST, 20.5x the 30-day avg

** Stock fell 2.9% in the reporting quarter, but rose 15.3% in Jan. 2024

($1 = 83.0566 Indian rupees)

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

** Shares of Unichem Laboratories UNLB.NS rise as much as 7.3% to 479 rupees, a record high

** Pharmaceutical firm gets U.S.FDA's abbreviated new drug application approval for its Doxazosin tablets, used for treatment of hypertension, to lower blood pressure

** More than 130,000 shares traded by 12:20 p.m. IST, 4x the 30-day avg

** More than 100,000 shares of co traded in a single session only once in Dec qtr

** Stock rose 28.6% in 2023, marking second straight year of gains

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

Dec 4 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• SOLD BALANCE STAKE HELD IN OPTIMUS DRUGS TO SEKHMET FOR AGGREGATE CONSIDERATION OF 674.7 MILLION RUPEES

Source text for Eikon: ID:nNSE9yNlY4

Further company coverage: UNLB.NS

(([email protected];))

** IIFL Alternative Research expects nine Indian companies to be added to MSCI India Standard index on Nov. 14

** IIFL expects most inflows into IndusInd Bank INBK.NS and Persistent Systems PERS.NS

** Says Zomato ZOMT.NS, DLF DLF.NS and Hindustan Aeronautics HIAE.NS likely to see biggest rise in weightage

** Says existing index members Reliance Industries RELI.NS, Sun Pharma SUN.NS, Infosys INFY.NS, L&T LART.NS could see outflows and drop in weightage and outflows

** Expects no deletions from MSCI India Standard index

** IIFL also expects around 32 small-cap additions into the MSCI India Small-Cap index

** Sees Unichem Labs UNLB.NS, Precision Camshafts PRCM.NS, Gateway Distriparks GATW.NS among likely additions and Vinati Organics VNTI.NS, Solar Industries SLIN.NS, BHEL BHEL.NS among deletions

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

Oct 3 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• RECEIVED A SHOW CAUSE CUM DEMAND NOTICE FROM ASST. COMMISSIONER OF STATE TAX

• SHOW CAUSE CUM DEMAND NOTICE ALLEGING TAX DEMAND OF 27.4 MILLION RUPEES

Further company coverage: UNLB.NS

(([email protected];))

Sept 1 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• SCHEMES OF HDFC MUTUAL FUND RAISE STAKE IN UNICHEM LABORATORIES TO 7.41% FROM 5.34% - EXCHANGE FILING

Source text for Eikon: ID:nBSE6bM2TF

Further company coverage: UNLB.NS

(([email protected];))

Aug 29 (Reuters) - Unichem Laboratories Ltd UNLB.NS:

• RECEIVED ANDA APPROVAL FOR ITS PRASUGREL TABLETS FROM USFDA

• TO MARKET A GENERIC VERSION OF EFFIENT

Source text for Eikon: ID:nBSEb3sDzY

Further company coverage: UNLB.NS

(([email protected];))